NanoBio's lead vaccine candidate, NB-1008, is a seasonal influenza vaccine administered intranasally. In a recently completed Phase 1 clinical study, NB-1008 was well-tolerated and elicited both ...
ANN ARBOR (WWJ) --NanoBio Corp. will get an initial contract of $5.5 million and up to $5 million more to devleop its nanoemulsion technology to improve the performance of flu vaccines. The grant came ...
Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. Ann Arbor-based NanoBio Corp., considered by many as ...
There has been a recent eruption (sorry 'bout that) of research geared toward discovering the first vaccine to treat and/or prevent genital herpes. You can add one more contender — Michigan-based ...
ANN ARBOR, Mich., May 7, 2018 /PRNewswire/ -- NanoBio Corporation, a clinical-stage biopharmaceutical company, today announced that it has changed its corporate name to BlueWillow Biologics ® in ...
ANN ARBOR, Mich. (October 13, 2009) -NanoBio Corporation today announced an award from the National Institute of Allergy and Infectious Diseases, a Division of The National Institute of Health, to ...
Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. Ann Arbor-based NanoBio Corp. announced at a medical ...
Nanoemulsion Adjuvanted Vaccines Continue to Demonstrate Positive Pre-Clinical Results in Genital Herpes, HIV and Chlamydia ANN ARBOR, Mich., (December 2, 2015) – NanoBio Corporation, a ...
NanoBio will receive a subcontract of approximately $4.1 million over the research period to support efforts aimed at developing nanoemulsion-based mucosal vaccine adjuvants for a wide variety of ...
ANN ARBOR, Mich.--(BUSINESS WIRE)--Researchers from NanoBio Corporation and the University of Michigan Medical School today announced the receipt of a $1.5 million grant from the Department of Defense ...
No approved vaccine exists today for RSV, which results in an estimated 900,000 hospitalizations annually in the U.S. and Europe ANN ARBOR, Mich. (November 30, 2010) - NanoBio Corporation announced ...
ANN ARBOR, Mich., Oct. 8, 2020 /PRNewswire/ -- BlueWillow Biologics ®, a clinical-stage biopharmaceutical company, is pleased to announce the launch of NanoBio ® Protect (NanoBio ®), the first alcohol ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results